Already have an ACS ID? Log in
This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.
Renew your membership, and continue to enjoy these benefits.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Already have an ACS ID? Log in here
Already an ACS Member? Log in here
$160 Regular Members & Society Affiliates
$55 Graduate Students
$25 Undergraduate Students
ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer.
$80 Regular Members
ACS’s Standard Package lets you stay up to date with C&EN, stay active in ACS, and save.
$0 Community Associate
ACS’s Basic Package keeps you connected with C&EN and ACS.
Your account has been created successfully, and a confirmation email is on the way.
Your username is now your ACS ID.
Most Popular in Business
- Will Japan run on ammonia?
- Is ammonia the fuel of the future?
- C&EN’s Global Top 50 chemical firms for 2021
- What is hand sanitizer, and does it keep your hands germ-free?
- Podcast: The helium shortage that wasn’t supposed to be
- What are glow sticks, and what’s the chemical reaction that makes them light up?
Symeres, a Dutch contract research organization (CRO) serving the drug industry, has acquired Organix, a Massachusetts-based organic chemistry CRO with a focus on lipids. Symeres says Organix has annual sales of over $10 million and about 45 employees, most of whom are PhD chemists. Symeres says the purchase will take its annual sales to about $95 million and provide its first outpost in the US, where it generates close to half its revenues.
Article:
This article has been sent to the following recipient:
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter
Sign up for C&EN’s must-read weekly newsletter
Copyright © 2022 American Chemical Society. All Rights Reserved.
